Cardioline acquires Cardios to expand global telecardiology footprint

Backed by ARCHIMED, the deal strengthens connected cardiac diagnostics with integrated Holter, ABPM, and telemedicine solutions

Ferrotec launches fast & flexible DNA/RNA isolation kit aimed at streamlining lab workflows

Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics

Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies

Gleneagles BGS Hospital launches HEAL Health Card to expand access to affordable care

The initiative is designed to benefit patients as well as healthcare providers by streamlining access to consultations, diagnostics, and essential care services

Evonik and Higuchi launch “Open Pharma Lab” in Yokohama to accelerate oral drug Innovation

EUDRAGIT polymers remain a cornerstone technology in oral drug delivery

FDA okays AstraZeneca’s triple therapy Breztri for asthma

The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device

Cubo set to transform decentralised diagnostics with Compact RT-PCR innovation

Avio Smart Market Stack Limited and Huwel Lifesciences unveil portable, cost-efficient molecular testing platform

NADMED Limited appoints James Lee as CEO to drive global expansion

Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation

The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings

With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints

Biosimilars gain momentum as US market sees 92 approvals: Samsung Bioepis report

Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation